Centessa Pharmaceuticals (CNTA) News Today → No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (From Hedgeye) (Ad) Free CNTA Stock Alerts $8.80 -0.12 (-1.35%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 5, 2024 | marketbeat.comAffinity Asset Advisors LLC Cuts Stake in Centessa Pharmaceuticals plc (NASDAQ:CNTA)Affinity Asset Advisors LLC cut its holdings in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 21.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 795,729 shares of the companyJune 5, 2024 | americanbankingnews.comCentessa Pharmaceuticals (NASDAQ:CNTA) & Argos Therapeutics (OTCMKTS:ARGSQ) Critical ComparisonJune 2, 2024 | americanbankingnews.comCentessa Pharmaceuticals (NASDAQ:CNTA) Trading 5.3% Higher May 31, 2024 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Shares Up 5.3%Centessa Pharmaceuticals (NASDAQ:CNTA) Trading Up 5.3%May 31, 2024 | marketbeat.comFranklin Resources Inc. Boosts Stake in Centessa Pharmaceuticals plc (NASDAQ:CNTA)Franklin Resources Inc. lifted its holdings in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 34.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,115,817 shares of the company's stock aMay 21, 2024 | globenewswire.comCentessa Pharmaceuticals to Participate in Upcoming Investor ConferencesMay 16, 2024 | marketbeat.comQ2 2024 Earnings Forecast for Centessa Pharmaceuticals plc Issued By Leerink Partnrs (NASDAQ:CNTA)Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) - Leerink Partnrs upped their Q2 2024 earnings estimates for shares of Centessa Pharmaceuticals in a research report issued to clients and investors on Monday, May 13th. Leerink Partnrs analyst D. Risinger now expects that the company willMay 14, 2024 | markets.businessinsider.comBuy Rating on Centessa Pharmaceuticals Based on Strong Pipeline and Financial HealthMay 13, 2024 | investorplace.comCNTA Stock Earnings: Centessa Pharmaceuticals Beats EPS for Q1 2024May 13, 2024 | finance.yahoo.comCentessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024May 13, 2024 | globenewswire.comCentessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024May 13, 2024 | marketbeat.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Sees Large Increase in Short InterestCentessa Pharmaceuticals plc (NASDAQ:CNTA - Get Free Report) was the target of a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 1,790,000 shares, an increase of 39.8% from the April 15th total of 1,280,000 shares. Based on an average daily volume of 335,100 shares, the days-to-cover ratio is presently 5.3 days. Approximately 3.0% of the company's stock are sold short.April 24, 2024 | seekingalpha.comCentessa: Hemophilia B Data Readout In 2024 Is Major Turning PointApril 24, 2024 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume IncreaseCentessa Pharmaceuticals (NASDAQ:CNTA) Sees Unusually-High Trading VolumeApril 24, 2024 | nasdaq.comCentessa Pharma Prices Public Offering Of About 10.81 Mln ADSs At $9.25/ADSApril 23, 2024 | globenewswire.comCentessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary SharesApril 23, 2024 | globenewswire.comCentessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary SharesApril 23, 2024 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 3.3%Centessa Pharmaceuticals (NASDAQ:CNTA) Trading Down 3.3%April 22, 2024 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap Up to $10.57Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap Up to $10.57April 22, 2024 | baystreet.caCentessa Gains on New Product NewsApril 22, 2024 | globenewswire.comCentessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024April 12, 2024 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 5.3%Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Down 5.3%April 12, 2024 | markets.businessinsider.comBuy Rating Affirmed for Centessa Pharmaceuticals Amid Promising ORX750 Prospects and Favorable Trial ResultsApril 11, 2024 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Trading Up 6.3%Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Up 6.3%April 8, 2024 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap Up to $10.37Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap Up to $10.37April 1, 2024 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Trading Down 3.6%Centessa Pharmaceuticals (NASDAQ:CNTA) Trading Down 3.6%April 1, 2024 | marketbeat.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven brokerages that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and five have assigned a buy recApril 1, 2024 | marketbeat.comBMO Capital Markets Reiterates Outperform Rating for Centessa Pharmaceuticals (NASDAQ:CNTA)BMO Capital Markets reiterated an "outperform" rating and set a $15.00 price objective on shares of Centessa Pharmaceuticals in a research report on Monday.March 29, 2024 | msn.comCNTA Stock Earnings: Centessa Pharmaceuticals Beats EPS for Q4 2023March 28, 2024 | finanznachrichten.deCentessa Pharmaceuticals plc: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023March 28, 2024 | finance.yahoo.comCentessa Pharmaceuticals PLC (CNTA) Earnings: A Detailed Look at Q4 and Full-Year 2023 ResultsMarch 28, 2024 | globenewswire.comCentessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023March 27, 2024 | finance.yahoo.comCentessa Pharmaceuticals PLC Chief People Officer Sells Company SharesMarch 27, 2024 | insidertrades.comInsider Selling: Centessa Pharmaceuticals plc (NASDAQ:CNTA) Insider Sells 51,160 Shares of StockMarch 26, 2024 | marketbeat.comCentessa Pharmaceuticals plc (NASDAQ:CNTA) Insider Karen M. Anderson Sells 51,160 SharesCentessa Pharmaceuticals plc (NASDAQ:CNTA - Get Free Report) insider Karen M. Anderson sold 51,160 shares of the firm's stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $11.88, for a total value of $607,780.80. Following the sale, the insider now directly owns 71,525 shares of the company's stock, valued at $849,717. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.March 26, 2024 | finance.yahoo.com7 Biotech Stocks Ready to Ride the Sector’s ResurgenceMarch 25, 2024 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Trading Down 5.6%Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 5.6%March 21, 2024 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 52-Week High at $12.41Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 1-Year High at $12.41March 20, 2024 | wsj.comCentessa Pharmaceuticals PLC ADRMarch 19, 2024 | investing.comCentessa Pharmaceuticals PLC ADR (CNTA)March 18, 2024 | investorplace.com7 Biotech Stocks Ready to Ride the Sector's ResurgenceMarch 16, 2024 | finance.yahoo.comCNTA Apr 2024 7.500 putMarch 16, 2024 | finance.yahoo.comCNTA Apr 2024 5.000 callMarch 16, 2024 | finance.yahoo.comCNTA Jul 2024 7.500 putMarch 12, 2024 | finance.yahoo.comPrivate equity firms who have a significant stake must be disappointed along with institutions after Centessa Pharmaceuticals plc's (NASDAQ:CNTA) market cap dropped by US$139mMarch 12, 2024 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Up 6.7%Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Up 6.7%March 11, 2024 | marketbeat.comCentessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 4%Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 4%March 8, 2024 | marketbeat.comAdage Capital Partners GP L.L.C. Purchases 580,500 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)Adage Capital Partners GP L.L.C. increased its position in shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) by 25.8% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,830,500 shares of theMarch 7, 2024 | markets.businessinsider.comUpgraded Buy Rating and Price Target for Centessa Pharmaceuticals on SerpinPC’s Market PotentialMarch 7, 2024 | marketbeat.comLeerink Partnrs Research Analysts Lower Earnings Estimates for Centessa Pharmaceuticals plc (NASDAQ:CNTA)Centessa Pharmaceuticals plc (NASDAQ:CNTA - Free Report) - Research analysts at Leerink Partnrs decreased their FY2024 EPS estimates for shares of Centessa Pharmaceuticals in a research note issued on Tuesday, March 5th. Leerink Partnrs analyst D. Risinger now expects that the company will post e Get Centessa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTA and its competitors with MarketBeat's FREE daily newsletter. Email Address Top 5 Tech Stocks to Buy for 2024 (Ad)The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution… Click below for your free report "Top 5 Tech Stocks to Buy in 2024", CNTA Media Mentions By Week CNTA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNTA News Sentiment▼0.340.76▲Average Medical News Sentiment CNTA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNTA Articles This Week▼22▲CNTA Articles Average Week Get Centessa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SRRK News OCGN News ALXO News AGEN News VTYX News MCRB News RPTX News ACRS News HCM News PBH News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNTA) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored📈 Alert: Gold Reaches New All Time High Amidst Inflation DataCentral Banks Have bought More Gold in the last 2 years than in all of history combined. That's right, the SAM...All American Assets | Sponsored